Announced Wed, 8 Jul · 14:37 IST
Fortis Healthcare board approves re-appointment of MD and CEO Dr. Raghuvanshi
Management Changes View source PDF
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.2%1-day move
₹971.60
prior close
₹939.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.3+0.4+0.4-2.2-0.4-0.7+0.1+0.5-2.0————
Up moveDown movePending
AI summary
Fortis Healthcare board on July 8, 2026 approved the re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director and CEO for a further two years effective March 19, 2027, subject to shareholder approval. His current term ends March 18, 2027. Dr. Raghuvanshi, aged about 64, is a cardiac surgeon with over 38 years of healthcare experience, including 18 plus years at Narayana Health. He is not debarred from the capital markets and is not related to any other director.
Likely market impact
Continuity at the top. Shareholder approval is pending. No change in leadership, likely neutral to mildly positive for stability.